Cerevel Therapeutics
About:
Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.
Website: https://www.cerevel.com
Twitter/X: CerevelTx
Top Investors: Pfizer, RA Capital Management, Fidelity, Invus, Perceptive Advisors
Description:
Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson’s disease and substance use disorder.
$1.9B
$50M to $100M
Boston, Massachusetts, United States
2018-10-01
251-500
2023-10-11
Delisted
© 2025 bioDAO.ai